NNelo Trade
← Back to Market News
October 14, 2026 at 11:23 AM UTC

Aquestive Therapeutics, Inc. reports material agreement in SEC 8-K

Aquestive Therapeutics, Inc. filed an 8-K covering a material definitive agreement. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: October 14, 2026 at 11:21 AM UTC

Open official source